These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 16291077
1. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease. Celli BR, Calverley PM, Rennard SI, Wouters EF, Agusti A, Anthonisen N, Macnee W, Jones P, Pride N, Rodriguez-Roisin R, Rossi A, Wanner A. Respir Med; 2005 Dec; 99(12):1546-54. PubMed ID: 16291077 [Abstract] [Full Text] [Related]
2. [The importance of the at risk COPD patients (Stage 0) and clinical differences]. Kömüs N, Tertemiz KC, Sevinç C. Tuberk Toraks; 2008 Dec; 56(4):382-9. PubMed ID: 19123073 [Abstract] [Full Text] [Related]
3. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease]. Sleszycka J, Woźniak K, Banaszek M, Wiechno W, Domagała-Kulawik J. Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871 [Abstract] [Full Text] [Related]
4. Correlation between serum biomarkers and BODE index in patients with stable COPD. Liu SF, Chin CH, Wang CC, Lin MC. Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260 [Abstract] [Full Text] [Related]
5. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. N Engl J Med; 2004 Mar 04; 350(10):1005-12. PubMed ID: 14999112 [Abstract] [Full Text] [Related]
6. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index. Medinas Amorós M, Mas-Tous C, Renom-Sotorra F, Rubí-Ponseti M, Centeno-Flores MJ, Gorriz-Dolz MT. Chron Respir Dis; 2009 Mar 04; 6(2):75-80. PubMed ID: 19411567 [Abstract] [Full Text] [Related]
7. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study. Montes de Oca M, Tálamo C, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, Pertuzé J, Moreno D, Halbert RJ, Menezes AM, PLATINO Team. Respir Med; 2008 May 04; 102(5):642-50. PubMed ID: 18314321 [Abstract] [Full Text] [Related]
9. [Pulmonary function in first generation children of chronic obstructive pulmonary disease (COPD) patients: assessment of related predicting factors]. Lu B, He Q, Chen Q, Huang X, Li J. Zhonghua Yi Xue Za Zhi; 2002 Aug 25; 82(16):1136-9. PubMed ID: 12425829 [Abstract] [Full Text] [Related]
10. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases. Majumdar S, Sen S, Mandal SK. J Indian Med Assoc; 2007 Oct 25; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952 [Abstract] [Full Text] [Related]
11. Global assessment of the COPD patient: time to look beyond FEV1? Papaioannou AI, Loukides S, Gourgoulianis KI, Kostikas K. Respir Med; 2009 May 25; 103(5):650-60. PubMed ID: 19167871 [Abstract] [Full Text] [Related]
12. Future perspectives in COPD. Celli B, Goldstein R, Jardim J, Knobil K. Respir Med; 2005 Dec 25; 99 Suppl B():S41-8. PubMed ID: 16256325 [Abstract] [Full Text] [Related]
13. Measuring the effects of COPD on the patient. Jones P, Lareau S, Mahler DA. Respir Med; 2005 Dec 25; 99 Suppl B():S11-8. PubMed ID: 16236492 [Abstract] [Full Text] [Related]
14. Predictors of mortality in COPD. Celli BR. Respir Med; 2010 Jun 25; 104(6):773-9. PubMed ID: 20417082 [Abstract] [Full Text] [Related]
16. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms. Lindberg A, Larsson LG, Rönmark E, Jonsson AC, Larsson K, Lundbäck B. COPD; 2007 Mar 25; 4(1):5-13. PubMed ID: 17364672 [Abstract] [Full Text] [Related]